VeriMomVeriMom

dihydroartemisinic acid é seguro durante a gravidez?

No EU Cosmetic Regulation listing (Annex II/III), no harmonised CLP classification, no SCCS or CIR safety assessment located for DHAA, and no peer‑reviewed reproductive/developmental toxicity studies on DHAA were identified. PubChem/PubChemLite and the literature describe DHAA as an artemisinin precursor but do not report reproductive hazard data for DHAA itself; therefore default hazard and mechanism scores are 0. Moderate lipophilicity (predicted logP ≈3.7, MW 236) suggests low but measurable potential for dermal absorption from a cosmetic formulation (e=1). ([pubchemlite.lcsb.uni.lu](https://pubchemlite.lcsb.uni.lu/e/compound/11020893?utm_source=openai))

Ingredientes
dihydroartemisinic acid
SEM RISCOS CONHECIDOS
93
/100
0

Related ingredients

Frequently asked questions

dihydroartemisinic acid é seguro durante a gravidez?
No EU Cosmetic Regulation listing (Annex II/III), no harmonised CLP classification, no SCCS or CIR safety assessment located for DHAA, and no peer‑reviewed reproductive/developmental toxicity studies on DHAA were identified. PubChem/PubChemLite and the literature describe DHAA as an artemisinin precursor but do not report reproductive hazard data for DHAA itself; therefore default hazard and mechanism scores are 0. Moderate lipophilicity (predicted logP ≈3.7, MW 236) suggests low but measurable potential for dermal absorption from a cosmetic formulation (e=1). ([pubchemlite.lcsb.uni.lu](https://pubchemlite.lcsb.uni.lu/e/compound/11020893?utm_source=openai))
dihydroartemisinic acid é seguro durante a amamentação?
Same evidence base as pregnancy: no regulatory or peer‑reviewed data indicating reproductive or lactation-specific hazard for DHAA. With no data of transfer into milk for DHAA, exposure scoring follows the adult topical route (low but measurable dermal absorption, e=1). No breastfeeding‑specific studies were found. ([pubchemlite.lcsb.uni.lu](https://pubchemlite.lcsb.uni.lu/e/compound/11020893?utm_source=openai))
dihydroartemisinic acid é seguro para a pele do bebê?
No infant‑specific toxicity or developmental dermatotoxicity data were found. Following your rules, because adult topical exposure is scored as measurable (e=1) and the compound is moderately lipophilic (logP ~3.7, MW 236) infant exposure is increased by +1 for immature barrier/higher SA:BW, giving e=2. Hazard and mechanism remain 0 in absence of reproductive/ED/teratogenic evidence. ([pubchemlite.lcsb.uni.lu](https://pubchemlite.lcsb.uni.lu/e/compound/11020893?utm_source=openai))
Como o VeriMom pontua dihydroartemisinic acid?
O VeriMom pontua dihydroartemisinic acid em 93/100 (sem riscos conhecidos) com base no status EU CosIng, classificações de perigo ECHA e estudos revisados por pares no PubMed. Nosso pipeline de pontuação é totalmente transparente.
Quais são as alternativas seguras a dihydroartemisinic acid na gravidez?
Veja nossa lista curada de alternativas seguras a dihydroartemisinic acid com base em função semelhante e classificação sem riscos conhecidos.

Verifique qualquer rótulo em 2 segundos

Baixe o VeriMom grátis — escaneie qualquer produto e veja a pontuação de segurança na gravidez instantaneamente.

Aviso Médico

Estas informações são apenas para fins educacionais e não constituem aconselhamento médico. As pontuações de segurança são baseadas em dados publicamente disponíveis e podem não refletir todos os riscos. Sempre consulte seu profissional de saúde antes de usar qualquer produto durante a gravidez ou amamentação.

Tenha a experiência completa no app VeriMom